BiologicalDrug
rGLP-1 protein clinical trials
Also written albiglutide and GSK716155.
How studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
32 studies that test it; most in 2010 (8)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 7 |
| 2010 | 8 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 32 · Other 0
Often tested with
Tested in the same studies.
Insulin Glargine (2) · Insulin Lispro (1) · Warfarin (1) · Contraceptives, Oral (1) · Digoxin (1) · Simvastatin (1) · Moxifloxacin (1) · Sitagliptin (1)
Studies
Open first, then newest update. How each study uses rGLP-1 protein is read from its arms, and is right about nine times in ten.
Testing it · 32
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusCompletedPhase 3GlaxoSmithKlineNCT02229227Written as Albiglutide
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy SubjectsTerminatedPhase 4GlaxoSmithKlineNCT02802514Written as Albiglutide 50mg
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus SubjectsTerminatedPhase 4GlaxoSmithKlineNCT02793154Written as Albiglutide
- Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus SubjectsTerminatedPhase 4GlaxoSmithKlineNCT02750930Written as Albiglutide
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusCompletedPhase 4GlaxoSmithKlineNCT02465515Written as Albiglutide 30 mg
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes MellitusWithdrawnPhase 3GlaxoSmithKlineNCT03015519Written as Albiglutide
- A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy SubjectsCompletedPhase 4GlaxoSmithKlineNCT02496221Written as Albiglutide 50 mg
- Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT00394030Written as GSK716155 subcutaneous injections
- Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.CompletedPhase 1GlaxoSmithKlineNCT00537719Written as GSK716155
- A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart FailureCompletedPhase 2GlaxoSmithKlineNCT01357850Written as GSK716155
- Clinical Assessment of GSK716155 for Type 2 Diabetes MellitusCompletedPhase 1GlaxoSmithKlineNCT00530309Written as GSK716155 for injection
- A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.CompletedPhase 1GlaxoSmithKlineNCT00938158Written as albiglutide
- A Drug Interaction Study With Albiglutide and WarfarinCompletedPhase 1GlaxoSmithKlineNCT01147731Written as warfarin plus albiglutide
- An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .CompletedPhase 1GlaxoSmithKlineNCT01077505Written as albiglutide
- A Drug Interaction Study of Albiglutide and DigoxinCompletedPhase 1GlaxoSmithKlineNCT01147718Written as digoxin plus albiglutide
- A Drug Interaction Study of Simvastatin and AlbiglutideCompletedPhase 1GlaxoSmithKlineNCT01147692Written as simvastatin plus albiglutide
- Albiglutide Thorough ECG Study in Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT01406262Written as Albiglutide
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedPhase 3GlaxoSmithKlineNCT01098539Written as albiglutide
- A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.CompletedPhase 3GlaxoSmithKlineNCT01128894Written as albiglutide
- Dose Ranging Study of Albiglutide in Japanese SubjectsCompletedPhase 2GlaxoSmithKlineNCT01098461Written as albiglutide
See all 32 studies that test rGLP-1 protein →
Given in every arm · 1 — rGLP-1 protein is usual care beside what is tested
As the comparator · 1 — what is tested is compared with rGLP-1 protein
Codes
What other systems call rGLP-1 protein · ClinicalTrials.gg INT005382
- MeSH (NLM) C534611rGLP-1 proteinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 5E7U48495EALBIGLUTIDEConfirmed FDA, NLM
- RxNorm 1534763One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C534611 | rGLP-1 protein | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 5E7U48495E | ALBIGLUTIDE | Confirmed FDA, NLM |
| RxNorm | 1534763 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.